Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PKB171 post-coital intravaginal gel in couples with mild male factor infertility
2023-503850-11-00Phase 3Authorised
- Sponsor
- Prokrea BCN
- Start
- Oct 2025
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pentoxifylline PKB171 gel and pentoxifylline in male infertility, oligospermia and asthenospermia (2 arms), sponsored by Prokrea BCN. Primary endpoint: Clinical pregnancy rate. Planned start Oct 2025; status: authorised.
02
Drugs
pentoxifylline PKB171 gelpentoxifylline
03
Conditions
male infertilityoligospermiaasthenospermia
Beyond the preview
Go deeper on 2023-503850-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503850-11-00.